Welcome to Scientific Scholar

Scientific Scholar, USA, established with the aim of publishing scientific
journals. The mission of the company is “Share, Learn and Improve”.

International Journal of Molecular and Immuno Oncology (IJMIO)

Scientific Scholar

International Journal of Molecular and Immuno Oncology (IJMIO) is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Molecular Biological and Immunological aspects of Oncology. The journal is owned by the Alms Tech LLP and published by the Scientific Scholar.

IJMIO is a peer-reviewed 3 (three) issues journal that is published both online and in print jointly by Molecular Oncology Society and Immuno Oncology Leadership Network. It is published by Scientific Scholar. The journal’s full text is available online at (https://ijmio.com). IJMIO is an Open Access journal, and online access to full text articles is provided at no charge for non-commercial use. The journal does not charge for submission or acceptance of manuscripts.

IJMIO employs the highest standards in publishing, backed by the years of experience of the Molecular Oncology Society and Immuno Oncology Leadership Network. The journal follows stringent peer-review and editorial policies that allow for the selection of high-quality work to be published. All manuscripts are evaluated by peer-review for their quality of science (including novelty, technical methodology, and integrity). The editorial policy is to require all authors to disclose any relevant financial associations and declare that financial interests have not influenced the content of the manuscript being published. This is in keeping with the high ethical standards we strive to ensure for all work published in IJMIO.

Focus & Scope

International Journal of Molecular and Immuno Oncology (IJMIO) is dedicated to providing a platform for highlighting novel and relevant research and exchange of knowledge at the crossroads of bench and bedside research. The goal is to provide information in an understandable format for clinicians and keep up with the fast-paced developments in Molecular Biology and Immunology related to Oncology.


Our audience includes Molecular Oncologists, Immunologists, medical professionals and students.

To submit a new manuscript visit– https://editorialassist.com/ijmio

For more details visit the journal website – https://ijmio.com/